Eli Manning isn’t ready to say what his future holds: ‘This is all I know’

  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

United States Headlines News

United States Latest News,United States Headlines

It's unclear if the Giants will bring back their starting quarterback, who is about to turn 38, for another season.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

That’s some Shawshank shit.

From a San Diego charger fan, I say it is a fitting end to his career. Time to go make papa John's commercials

Should he retire?

If any one saw the last minutes of the Packer/Giant game would have the answer now. All Manning had to do was get 1 first down after a great run back and they would have been ready for a game winning field goal.

Don’t do sports Washington Post. Just don’t...

Come on in Eli, the water's fine. Most of us change jobs/careers several times in our lifetimes.

Poor multimillionaire

He’ll be back.

I've always like Eli and wish him well. Still, I totally enjoyed that last seconds victory by the Cowboys yesterday. WOOOOOOHOOOOOO!

To retire better

He’s running

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 95. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Giants GM Gettleman not committed to Manning in '19The New York Giants stuck with quarterback Eli Manning through the 2018 season, ... .. stop smiling .. we have no one else :) EmmaVigeland ربنا معاك Yeah it time !!There is no fire there!!
Source: Reuters - 🏆 2. / 97 Read more »

Eli Lilly to acquire Loxo Oncology for about $8 billion
Source: CNBC - 🏆 12. / 72 Read more »

Eli Lilly to Buy Loxo Oncology in Deal It Values at About $8 BillionEli Lilly said it is buying Loxo Oncology for $235 a share—a 68% premium from Friday’s closing price—in cash, a deal that expands the biopharmaceutical company’s oncology-treatment portfolio. They got cash like that lying around? Cancer is a good business it seems. Can we get Universal Health Care please Wow.let's spread cancer to everyone Wonder how much the cost of insulin will soar to finance this gamble
Source: WSJ - 🏆 98. / 63 Read more »

Eli Lilly to buy Loxo Oncology in $8 billion cancer pushThe pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
Source: trtworld - 🏆 101. / 63 Read more »

Eli Lilly to spend about $8B on Loxo OncologyEli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and... Hmm...Another Individual Attempting a Monopoly? If you want to know why we do not have a cure for cancer it is because this amount of money is exchanging hands. Treat not cure.
Source: ABC - 🏆 471. / 51 Read more »

Eli Lilly’s $8 bln cancer deal is a worthy wagerThe drug giant reckons it’ll take years to get a good return on its pricey acquisition of Loxo. But the upstart has had startling success figuring out why rare cancerous mutations occur, rather than where. Longer term, that should make for plenty of targets – and sticky prices. Breakingviews rob_cyran RoyalFamily Rp. 8.000.000,00 is FCO standart in Jakarta, Lilibeth. Breakingviews rob_cyran Start-up, no? 'Upstart' is something entirely different.
Source: Breakingviews - 🏆 470. / 51 Read more »

Eli Lilly CEO: Loxo acquisition can help us treat cancer globally'This is the future of cancer treatment, we believe.' Eli Lilly CEO David Ricks said that Loxo Oncology has 'harnessed the power of emerging science' and that Lilly's acquisition of Loxo can help treat cancer globally. For a price Never gonna happen...they make too much money off of giving everyone cancer then all the treatments and pills.
Source: CNBC - 🏆 12. / 72 Read more »

Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Source: MarketWatch - 🏆 3. / 97 Read more »

Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Source: CNBC - 🏆 12. / 72 Read more »

Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreCheck out the companies making headlines midday Friday.
Source: CNBC - 🏆 12. / 72 Read more »